Dr. Pascal Geldsetzer is an Assistant Professor of Medicine in the Division of Primary Care and Population Health and, by courtesy, in the Department of Epidemiology and Population Health. He is also affiliated with the Department of Biomedical Data Science, Department of Health Policy, King Center for Global Development, and the Stanford Centers for Population Health Sciences, Innovation in Global Health, and Artificial Intelligence in Medicine & Imaging.

Dr. Ian Chen's research focuses on elucidating the mechanisms of valvular heart disease using a variety of imaging, computational, machine learning, stem cell-based, and next-generation sequencing tools, with the long-term goal to translate mechanistic findings into personalized therapies for patients.

Dr. Raya Saab is a Professor at the Department Pediatrics, Division of Hematology, Oncology, and Stem Cell Transplant at Stanford. She is currently section chief of Pediatric Oncology, and her clinical expertise is in pediatric sarcoma and retinoblastoma. Dr. Saab's laboratory research aims to understand oncogenic pathways involved in tumor progression and invasion to identify novel therapeutic targets, focusing on the pediatric soft tissue tumor rhabdomyosarcoma.

Dr. Wu Liu is an associate professor and clinical medical physicist at Department of Radiation Oncology, Stanford University, Stanford, CA, USA. He was born in Beijing, China. He received B.S. degree in Astronomy from Nanjing University, Nanjing, China and M.S. degree in Astrophysics from Chinese Academy of Sciences, Beijing, China. He obtained his M.S. degree in Computer Science and Ph.D. degree in Medical Physics (2007) from University of Wisconsin-Madison, Madison, WI, USA. He then completed his postdoctoral training at Stanford University.

Dr. Andres Cardenas focuses on studying how environmental exposures influence epigenetic programming, health and disease from the prenatal period to aging. The goal of Dr. Cardenas's lab is to find epigenetic biomarkers of environmental exposures, health and disease susceptibility for prevention purposes.

Nature has created many powerful biomolecules that are hidden in organisms across kingdoms of life. Many of these biomolecules originate from microbes, which collectively contain the most diverse gene pool among living organisms. Dr. Alex Gao's lab is integrating high-throughput computational and experimental approaches to harness the vast diversity of genes in microbes to develop new antibiotics and molecular biotechnology, and to investigate the evolution of proteins and molecular mechanisms in innate immunity.

Dr. Priscilla Yang earned her PhD in Bio-organic Chemistry at the University of California, Berkeley. Following postdoctoral training in viral immunology at Scripps Research, she started her independent career at Harvard Medical School, where her laboratory combined chemical and pharmacological approaches to address fundamental and translational problems in virology.

Dr. Wei Gu is Assistant Professor of Pathology at Stanford University was trained as a physician, engineer, and scientist. He pioneered technologies in cell-free DNA 'liquid biopsy' testing, CRISPR diagnostics, clinical metagenomic sequencing, non-invasive prenatal testing, and COVID diagnostics. He has been awarded multiple extramural grants, including the Burroughs Wellcome Career Award, and a K08 from the National Cancer Institute. He is also a board-certified molecular and clinical pathologist and has a clinical practice within Stanford Healthcare.

Dr. Kacper Rogala is Assistant Professor at Stanford University School of Medicine with a joint appointment between the Department of Structural Biology and the Department of Chemical & Systems Biology. He is also a Leader in the Stanford Cancer Institute.

Dr. Melody Smith is a board-certified, fellowship-trained medical oncologist and hematologist. She is an assistant professor in the Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.